MINDBODY (NASDAQ:MB) Earning Somewhat Positive News Coverage, Accern Reports

Media coverage about MINDBODY (NASDAQ:MB) has been trending somewhat positive this week, Accern Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MINDBODY earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned news stories about the technology company an impact score of 45.6017526366842 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Several research firms have recently issued reports on MB. UBS Group restated a “buy” rating and set a $40.00 price objective (up previously from $34.00) on shares of MINDBODY in a report on Thursday, November 9th. BidaskClub downgraded shares of MINDBODY from a “buy” rating to a “hold” rating in a report on Friday. Zacks Investment Research lowered MINDBODY from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. Morgan Stanley upped their target price on MINDBODY from $34.00 to $37.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 30th. Finally, DA Davidson started coverage on MINDBODY in a research report on Wednesday, November 15th. They issued a “buy” rating and a $42.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. MINDBODY has an average rating of “Buy” and a consensus target price of $34.32.

Shares of MINDBODY (MB) traded up $0.20 during trading hours on Friday, hitting $30.90. The stock had a trading volume of 449,751 shares, compared to its average volume of 285,533. MINDBODY has a 52-week low of $21.57 and a 52-week high of $36.25. The stock has a market cap of $1,443.03, a price-to-earnings ratio of -81.32 and a beta of -0.08. The company has a quick ratio of 9.20, a current ratio of 9.20 and a debt-to-equity ratio of 0.06.

In related news, insider Kimberly Gail Lytikainen sold 36,868 shares of the stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $30.11, for a total value of $1,110,095.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Richard Lee Stollmeyer sold 17,739 shares of the stock in a transaction on Friday, December 1st. The shares were sold at an average price of $31.95, for a total value of $566,761.05. The disclosure for this sale can be found here. Insiders have sold a total of 92,348 shares of company stock worth $2,883,809 in the last quarter. Insiders own 8.22% of the company’s stock.

TRADEMARK VIOLATION WARNING: “MINDBODY (NASDAQ:MB) Earning Somewhat Positive News Coverage, Accern Reports” was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://ledgergazette.com/2018/02/12/mindbody-mb-earns-daily-news-impact-score-of-0-17.html.

About MINDBODY

MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with local business subscribers on its platform. The Company’s subscribers provide a range of wellness services to active consumers. Its integrated software and payments platform helps business owners in the wellness services industry run, market and build their businesses.

Insider Buying and Selling by Quarter for MINDBODY (NASDAQ:MB)

Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply